Login to Your Account

Adcoms Recommend Higher Standards for Calcitonin Drugs

By Mari Serebrov
Washington Editor

Tuesday, March 5, 2013
Drugmakers with calcitonin salmon products under development for postmenopause osteoporosis (PMO) may have to do a lot more work to get the drugs approved following a joint FDA advisory committee meeting Tuesday.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription